Smarca4 ATPase mutations disrupt direct eviction of PRC1 from chromatin

Area of Science:

• Epigenetics
• Molecular Biology
• Cancer Biology

Background:

• Trithorax-group proteins and BAF (mSWI/SNF) complexes antagonize Polycomb repressive complexes (PRCs).
• This antagonism is crucial for the tumor-suppressive functions of BAF subunits and implicated in neurodevelopmental disorders.
• The precise mechanisms of BAF-mediated opposition to Polycomb silencing remain unclear.

Purpose of the Study:

• To investigate how disease-associated mutations in BAF subunits affect the interaction with and opposition of Polycomb repressive complexes (PRCs).
• To elucidate the molecular mechanisms underlying the BAF-PRC antagonism in the context of development and disease.

Main Methods:

• Analysis of genome-wide PRC deposition and activity in cells with BAF mutations.
• Biochemical assays to assess direct binding between BAF and PRC1, focusing on SMARCA4 mutations.
• Utilizing a chemical-induced proximity assay to study the dynamics of BAF-Polycomb interactions.

Main Results:

• Recurrent disease-associated mutations in BAF subunits lead to increased genome-wide PRC deposition and activity.
• Specific SMARCA4 mutations disrupt direct BAF-PRC1 binding independently of chromatin, in an ATP-dependent manner.
• BAF complexes were observed to directly and rapidly evict Polycomb factors upon occupancy.

Conclusions:

• BAF complexes directly antagonize Polycomb silencing through a transient eviction mechanism.
• Disruption of BAF-PRC interactions by disease-associated mutations contributes to altered epigenetic states in development and disease.
• This study establishes a novel mechanism for BAF-PRC opposition, with implications for understanding cancer and neurodevelopmental disorders.